60 Degrees Pharmaceuticals, Inc.
SXTPW· Nasdaq
SXTPW60 Degrees Pharmaceuticals, Inc.
Filed Aug 14, 2024 · 10-Q · 45 days after period end · 0001213900-24-068673
| Metric | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|
| Revenue | $124.97K | $59.53K | $45.17K |
| Net Income | -$4.17M | -$3.34M | -$2.15M |
| EPS Diluted | -$21.12 | -$16.84 | -$0.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end
